SuperworthCNS Pharmaceuticals shares outstanding CNSP
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 6.8M
- On a year earlier
- +1747.5%
- more shares
CNS Pharmaceuticals had 6.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1747.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2023 | 169 | +242% |
| FY2022 | 49 | +60% |
| FY2021 | 31 | +63% |
| FY2020 | 19 | +13% |
| FY2019 | 17 | +43% |
| FY2018 | 12 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 6.8M | +1748% | |
| Q1 FY26 | 676.2K | +198% | |
| Q3 FY25 | 558.9K | +1427% | |
| Q2 FY25 | 370.1K | +59120% | |
| Q1 FY25 | 227.2K | +78387% | |
| Q3 FY24 | 36.6K | +26181% | |
| Q2 FY24 | 625 | +384% | |
| Q1 FY24 | 290 | +356% | |
| Q4 FY23 | 169 | +242% | |
| Q3 FY23 | 139 | +213% | |
| Q2 FY23 | 129 | +191% | |
| Q1 FY23 | 64 | +47% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on CNS Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.